Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Research team creates a promising new mass spectrometry-based blood lipid test.